- $10.79bn
- $10.51bn
- $3.28bn
- 100
- 31
- 91
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,846 | 2,478 | 2,765 | 2,988 | 3,283 |
Cost of Revenue | |||||
Gross Profit | 910 | 782 | 900 | 922 | 1,107 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,435 | 2,251 | 2,261 | 2,520 | 2,756 |
Operating Profit | 411 | 227 | 504 | 468 | 527 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 414 | 85.2 | 509 | 462 | 520 |
Provision for Income Taxes | |||||
Net Income After Taxes | 325 | 59.2 | 320 | 371 | 415 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 325 | 72.5 | 316 | 367 | 411 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 325 | 72.5 | 316 | 367 | 411 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.65 | 2.13 | 3.04 | 4.45 | 5.25 |
Dividends per Share |